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SUMMARY: The aim of the present research was to evaluate the anti-inflammatory activity of pumpkin seed 
oils (PSOs) of an Egyptian and European variety, in a rat model of adjuvant arthritis. Edema thickness, plasma 
tumor necrosis factor-α (TNF-α) and erythrocyte sedimentation rate (ESR) were determined as inflammatory 
biomarkers while malondialdehyde (MDA) and total antioxidant capacity (TAC) were assessed as indicative 
of oxidative stress. Chromosomal aberration, sperm shape abnormalities, and DNA fragmentations are cyto-
genetic parameters which aid in tracing inflammatory and oxidative activity. Phenolic contents and β-carotene 
were determined in PSOs. The results showed elevated ESR, plasma TNF-α, plasma MDA, liver cellular DNA 
fragmentation, bone marrow chromosomal aberration, sperm shape abnormalities with a reduction in plasma 
TAC and body weight gain in an adjuvant arthritis control compared to a healthy control. Administration of 
low and high doses of either Egyptian or European PSO improved all the aforementioned parameters with vari-
able degrees.
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RESUMEN: Actividad antiinflamatoria de dos variedades de aceite de semillas de calabaza en un modelo de 
artritis adyuvante en ratas. El objetivo de la presente investigación fue evaluar la actividad antiinflamatoria de 
aceites de calabaza (PSOs) de variedades egipcia y europea, en un modelo de rata con artritis adyuvante. El 
espesor del edema, el factor de necrosis tumoral (TNF-α) y la velocidad de sedimentación eritrocitaria (ESR) 
se determinaron como biomarcadores inflamatorios, mientras que el malondialdehído (MDA) y la capacidad 
antioxidante total (TAC) fueron evaluados como indicativos de estrés oxidativo. La aberración cromosómica, 
las anomalías de la forma del esperma y las fragmentaciones del ADN son parámetros citogenéticos que ayudan 
a localizar la actividad inflamatoria y oxidativa. Se determinaron contenidos fenólicos y β-caroteno en PSOs. 
Los resultados mostraron elevado ESR, TNF-α plasmático, MDA plasmática, fragmentación del ADN del 
hígado, aberración cromosómica de la médula ósea, anomalías de la forma espermática con una reducción del 
TAC plasmático y un aumento del peso corporal en el control de la artritis adyuvante en comparación con el 
control sano. La administración de dosis bajas y altas de PSO egipcia o europea mejoró todos los parámetros 
mencionados en grados variables.
PALABRAS CLAVE: Aceites de semillas de calabaza; Antiinflamatorio; Artritis adyuvante; β-Caroteno; Contenido 
fenólico
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1. INTRODUCTION
Oxidative stress and inflammation are the main 
causes of  many chronic diseases including rheu-
matoid arthritis (RA). Oxidative stress plays an 
important role in the initiation and progression 
of  joint diseases (Knight, 2000). Reactive oxygen 
species (ROS) cause oxidative damage which accu-
mulates during the life cycle, the radical-related 
damage affects DNA, proteins and lipids which 
have been proposed to play a key role in the devel-
opment of  arthritis.
RA is an autoimmune disease that causes 
chronic inflammation of  the joints and surround-
ing tissue with infiltration of  macrophages and 
activated T cells. The pathogenesis of  this disease 
is predominantly linked with the formation of 
free radicals at the site of  inflammation. The dis-
ease progression of  RA is associated with chronic 
soft tissue inflammation, which is often followed 
by bone and cartilage destruction of  inflamed 
joints (Anderson et  al., 2012). Oxidative injury 
and inflammation is reflected in increased levels 
of  serum TNF-α that has been shown to play a 
critical role in the onset and progression of  RA. 
The overproduction of  TNF-α could stimulate 
cartilage matrix degradation by inhibiting the pro-
duction of  proteoglycans and type II collagen and 
up-regulating the production of  matrix-degrading 
enzymes (Goldring, 2000). An excessive accumu-
lation of  ROS may cause cellular oxidative dam-
age to nucleic acids, proteins and chromosomal 
aberrations in the cells of  several systems and that 
could occur in RA as reported previously (Al-Okbi 
et al., 2011).
The inverse association between fruit and 
vegetable intake and the risk of  chronic diseases 
related to morbidity and mortality is often attrib-
uted to bioactive ingredients that may possess 
anti-inflammatory and antioxidant activity such 
as vitamins C and E, carotenoids and polyphe-
nols (Prakash and Gupta, 2009). Plant foods are 
rich sources of  such bioactive ingredients. The 
pumpkin seed is among the plant foods that con-
tain high levels of  bioactive ingredients, includ-
ing β-carotene, unsaturated fatty acids, phenolic 
compounds, phytosterols and tocopherols espe-
cially in the oil compartment. These functional 
food ingredients have been reported to possess 
both anti-inflammatory and antioxidant activi-
ties in hyper-cholesterolemic rats (Al-Okbi et al., 
2014).
The aim of  the present research was to assess 
the functional food ingredients, β-carotene and 
phenolic contents, in PSOs of  the Egyptian and 
European varieties. The main objective was to 
evaluate the PSOs’ anti-inflammatory activity and 
the related mechanism in a rat model of  chronic 
inflammation that simulates RA in humans.
2. MATERIALS AND METHODS
2.1. Plant materials
Egyptian pumpkin seeds (Cucurbita moschata, 
L. Family Curcubitaceae) were purchased from 
the local market, Cairo, Egypt. A European PSO 
(Cucurbita pepo, L. Family Cucurbitaceae var. 
styria) was obtained from Graz, Austria.
2.2. Animals
Male white albino rats of 100-110 g body weight 
were used in the present study. The animals were kept 
individually in stainless steel cages; water and food 
were given ad-libitum. The animal experiment was 
carried out adopting the Ethics Committee of the 
National Research Centre, Cairo, Egypt, and fol-
lowed the recommendations of the National Institutes 
of Health Guide for Care and Use of Laboratory 
Animals (Publication No. 85-23, revised 1985).
2.3. Major chemicals
Colchicine and Folin-Ciocalteu reagent were 
purchased from Sigma (USA) and Sigma-Aldrich, 
Germany, respectively. Freund’s complete adju-
vant (FCA) was supplemented from DIFCO 
LABORATORIES, Detroit, Michigan USA. All 
chemicals and solvents used were of high quality 
analytical grade.
2.4. Preparation of PSO
PSO was prepared from Egyptian pumpkin 
seeds by extraction using petroleum ether (40–60ºC) 
(Al-Okbi et al., 2014).
2.5. Determination of total phenolic content (TPC) 
of the oils
TPC was extracted from PSOs and determined 
colorimetrically using the Folin-Ciocalteu reagent 
(Singleton and Rossi, 1965). Absorbance was mea-
sured at 765 nm using a UVPC spectrophotom-
eter. Gallic acid was used as a standard and results 
were calculated as mg gallic acid equivalent (GAE) 
per gm of oil. The reaction was conducted in tripli-
cate and results were averaged.
2.6. Assessment of β-carotene in Egyptian and 
European PSO
β-Carotene was determined using the HPLC 
method (Hart and Scott, 1995). The exact weights 
of  2.5 grams from the Egyptian and European 
PSOs were weighed in two separate glass screw 
cap tubes. The oils were homogenized with 20 ml 
ethanol (HPLC) by vortex mixing (5 min), then 10 
ml of  hexane (HPLC) were added to each tube, 
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mixed for 2 min, centrifuged (5 min, 5000g) and 
the clear upper layer was carefully transferred to 
other glass screw cap tubes. The samples were 
re-extracted twice with hexane. Then 7 ml of  the 
hexane extracts were dried to completion under 
a nitrogen stream and re-suspended in 1 ml of 
50% ethanol for analysis by the HPLC System. 
HPLC conditions: Waters Melinnium 3.2 software 
using a system equipped with a binary pump sys-
tem (Waters 515), an auto-injector (Waters 717 
plus), a PDA detector (Waters 996), and a col-
umn heater (Spectra Physics SP8792). The com-
pound was separated on a 4.6 x 250 mm, 5  µm, 
YMC Carotenoid column (C-30 reverse-phase) 
purchased from Waters (Milford, MA), which 
was maintained at 35 °C. The following gradient 
system was used: methanol/water/triethylamine 
(90:10:0.1v/v/v) (A), and methanol/MTBE/trieth-
ylamine (6:90:0.1v/v/v) (B); gradient (min/%A) 
0/99, 8/99, 45/0, 50/0, and 53/99. The column was 
brought back to initial conditions, and allowed 
to equilibrate for 10 minutes before injection. All 
solvents were filtered and degassed before use. 
The concentration of  β-carotene in the samples 
was obtained by comparing its peak area with the 
peak area of  standard β-carotene in relation to 
concentration.
2.7. Preparation of dosage form
An emulsion of each oil was prepared using gum 
acacia to easily manage the rats’ oral dose. The same 
concentration of gum acacia was prepared in water 
(the vehicle) to be given to control groups of rats.
2.8. Preparation of diet
A balanced diet was prepared containing 11.9 
casein (10 protein), 10 sunflower oil, 45.73 corn 
starch, 22.87 sucrose, 5 cellulose, 1 vitamin mixture 
and 3.5 salt mixture as g./100g.
2.9. In-vivo study of the anti-inflammatory activity 
of PSO in rats
The potential anti-inflammatory effect of PSOs 
was evaluated in an adjuvant arthritis model 
(chronic inflammation model) of rats. Adjuvant 
arthritis (AA) was induced by subcutaneous injec-
tion of 0.3 ml FCA/rat into the sub-planter region 
of the right hind paw (Singh et al., 1992).
Thirty-six male albino rats were divided into 
6 groups, 6 rats each; all rats were fed a normal 
balanced diet throughout the experiment. The 
rats from the first group (control normal) received 
no medication or injection and were given a daily 
oral dose of  the vehicle for 21 days. Rats of  the 
second group (adjuvant arthritis control) were 
given a daily oral dose of  the vehicle for 21 days; 
the rats were treated with FCA 8 days from start-
ing vehicle dosing. The rats of  group 3 were given 
a daily oral dose of  Egyptian PSO (40 mg/Kg rat 
body weight) for 21  days along with treatment 
by FCA 8 days later from starting the oral dose. 
Rats of  group 4 were given a daily oral dose of 
Egyptian PSO (500 mg/Kg rat body weight) for 
21 days while FCA was injected 8 days from start-
ing the oral dose. The rats of  groups 5 and 6 were 
treated like groups 3 and 4, respectively but with 
applying the European PSO. The food intake and 
body weight of  rats were recorded once a week. At 
the end of  the experiment, total food intake, body 
weight gain and food efficiency ratio were calcu-
lated. Paw thickness was measured immediately 
before the induction of  arthritis (zero time) and at 
the end of  the experiment using Vernier caliper to 
assess the degree of  inflammation. The increase 
in the thickness of  the injected paw (inflamma-
tion thickness) of  the rats of  all groups was cal-
culated. Also, at the end of  the experiment, rats 
were anesthetized and blood samples were with-
drawn from the eye vein orbital after an overnight 
fast (16 h). Blood samples were divided into two 
parts. One was mixed with trisodium citrate (109 
mmol/L) for the determination of  the erythrocyte 
sedimentation rate (Westergren, 1921), the second 
part was mixed with heparin as anticoagulant, 
followed by centrifugation at 3000 rpm for 15 
min for separation of  plasma and determination 
of  TNF-α (Stepaniak et al., 1995), MDA (Satoh, 
1978) and total antioxidant capacity (Koracevic 
et al., 2001). ESR and TNF-α are both consid-
ered as inflammatory biomarkers. Plasma MDA 
and total antioxidant capacity were assessed for 
evaluating the oxidative stress and/or antioxidant 
status.
All rats were kept alive for an additional 24 hours 
and treated by intraperitoneal injection of  colchi-
cine at a concentration of  3 mg/kg body weight. 
After 2 hours of  injection, rats were anesthetized 
with ether and sacrificed; the liver was separated, 
washed with saline and received upon filter paper 
to remove any excess blood then wrapped with foil 
and kept at -20ºC until being analyzed for DNA 
fragmentation assay. The reproductive tract was 
exposed and the epididymus were excised. Both 
epididymus of  each rat were received in a tube 
containing saline. The femurs bones of  both legs 
of  each rat were also received on saline in another 
tube. Both epididymus and the bone marrow of  the 
femur were taken immediately for cytogenetic and 
chromosomal aberration tests.
For an extra cytogenetic study, two more groups 
were run parallel to the previous groups; each of 6 
rats; a group was given daily oral dose of Egyptian 
PSO (500mg/Kg rat body weight) and the other 
group was given the same dose from the European 
variety for 21 days and fed on balanced diet.
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2.10. Assessment of cytogenetic parameters
2.10.1. Chromosomal aberrations test
Bone marrow metaphases were prepared (Yosida 
and Amano, 1965). Bone-marrow cells from both 
femurs were collected in a 6-8 ml hypotonic solu-
tion of  KCl (0.075 M). The cell suspension was 
incubated for about 20 min. at 37 °C then centri-
fuged at 1000 rpm for 10 min. After discarding 
the supernatant, cells were fixed by re-suspending 
in freshly-prepared cold fixative methanol/ acetic 
acid (3:1), and centrifuged again for 10 min. at 
1000 rpm. The fixation step was repeated at least 
three times. Finally, the cells were re-suspended in 
the appropriate volume of  fixative and were spread 
by dropping the concentrated cell suspensions onto 
slides that had just been removed from the freezer. 
Five to seven slides were prepared for each rat. 
The slides were stained with 7% Giemsa in phos-
phate buffer (pH 6.8). One hundred well-spread 
Metaphases were analyzed per animal. Different 
chromosome aberrations including gaps, breaks, 
fragments and deletions were recorded.
2.10.2. Sperm shape abnormalities
The protocol recommended previously 
(Wyrobek, 1978) was used. Both epididymus from 
each rat were minced together with small scissors 
in physiological saline, pipetted up and down and 
then filtered into small test tubes to exclude large 
tissue fragments to which the volume was made up 
to 2 ml. Smears were prepared on clean dry slides. 
The slides were stained in 1% Eosin Y (aqueous). 
Six rats were taken for each treatment and at least 
three slides were prepared for each rat to study 
sperm abnormalities for microscopical examina-
tion. For each dose, at least 5000 sperms were 
assessed for morphological abnormalities of  the 
sperm shape.
2.10.3. DNA fragmentation assay
The method of  DNA fragmentation was car-
ried out (Perandones et al., 1993). Reagents 
used were hypotonic lysis buffer pH 8.0, 10% 
Trichloroaceticacid (TCA), 5% TCA and color 
reagent. Hypotonic lysis buffer was made from 
0.2%Triton X-100, 10mM Tris and 1mM EDTA 
while the color reagent consisted of  0.088M 
Diphenylamine (DPA), 98% v/v Glacial acetic 
acid, 1.5% v/v Sulphuric acid and 0.5% v/v 1.6% 
Acetaldehyde solution. The liver tissues (50 mg) 
were mechanically dissociated in 400 µL hypotonic 
lysis buffer to obtain cell lysate. The cell lysate was 
centrifuged at 13.800 xg for 15 minutes. The super-
natant containing small DNA fragments was sepa-
rated immediately, the supernatant and the pellet 
containing large pieces of  DNA, were used for the 
diphenylamine (DPA) assay.
2.10.3.1. Diphenylamine assay (DPA)
The colorimetric determination of DNA content 
was assessed (Perandones et al., 1993). Both the 
supernatant and the pellet were used for DPA assay 
after acid extraction of DNA. The pellet contain-
ing large fragments of DNA and cell debris was re-
suspended in a 400 µl hypotonic lysis buffer. TCA 
(10%) was added (400 μl) to both the supernatant 
and the re-suspended pellet. The tubes were centri-
fuged at 2000 rpm for 10 min. The precipitate was 
re-suspended in 400 µl of 5% TCA. The tubes were 
incubated at 80 ºC for 30 min. The supernatant con-
taining the extracted DNA was left to cool at room 
temperature. Two volumes of the color reagent were 
added to one volume of extracted DNA. The sam-
ples were stored at 4 ºC for 48h till the blue color was 
developed. The blue color was measured colorimet-
rically using a spectrophotometer at 578 nm. The 
percentage of DNA fragmentation in each sample 
was expressed by the formula: % DNA fragmenta-
tion = OD of supernatant x 100⁄OD of supernatant 
+ OD of pellet, where OD is the optical density.
2.11. Statistical analysis
Results of total phenolic content were expressed 
as mean ± SE with application of t-Students test. The 
results of the animal experiments were presented as 
the mean ± SE and were analyzed statistically using 
one-way analysis of variance ANOVA followed by 
LSD test. In all cases p < 0.05 was used as the cri-
terion for statistical significance. For the statistical 
analysis of chromosomal aberrations in bone mar-
row cells, the Chi-square test (X2 contingency table) 
was applied. One-way analysis of variance (ANOVA 
test) was applied to the data of sperm shape abnor-
malities and DNA fragmentation in liver cells.
3. RESULTS
3.1. β-carotene and total phenolic contents of PSOs
In Table 1, the European oil showed a higher 
β-carotene level compared with the Egyptian oil 
(28.5 and 17.9 µg/100g oil, respectively). In addition, 
Table 1. β-carotene and total phenolic content in PSOs 
Parameters Egyptian PSO European PSO
β-carotene (μg/100 g oil) 17.9 28.5
Total phenolic† (mg GAE/g 
oil)
1.71 ± 0.012 14 ± 0.15*
GAE: Gallic acid equivalent, †Total phenolic was calculated as 
mean ± SE, *Phenolic contents of European oil was significantly 
higher than that of the Egyptian oil,*P < 0.001.
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the studied oils showed the presence of total pheno-
lic content at 1.71 and 14 mg GAE/g in Egyptian 
and European oil, respectively. The total phenolic 
content of the European oil was significantly higher 
than that of the Egyptian variety.
3.2. In-vivo study of the anti-inflammatory activity 
of PSOs in rats
3.2.1. Assessments of Inflammation
The increase in foot thickness (thickness of 
inflammation) of the control arthritic rats at the end 
of the experiment compared with the rats given dif-
ferent oil treatments is shown in Table 2. Different 
doses of pumpkin oil produced a significant reduc-
tion in foot swelling compared to the arthritic con-
trol. Non-significant differences were observed 
between arthritic rats given different oil doses. 
Pumpkin oils exhibited a significant inhibition of 
inflammation ranging from 31% to 50%.
3.2.2. Biochemical and nutritional parameters of 
arthritic rats
The results of the biochemical changes in the dif-
ferent groups of rats in the adjuvant arthritis experi-
ment are shown in Table 3. Plasma TNF-α, MDA and 
ESR were significantly higher in arthritic rats than 
the normal control. The plasma level of total antioxi-
dants was significantly lower in the arthritic rats com-
pared to the normal control. Plasma TNF-α, MDA 
and ESR showed significant reductions in arthritic 
rats given different pumpkin oil doses compared to 
the arthritic control. In addition; the plasma level 
of total antioxidants was significantly higher in the 
arthritic rats given different oil treatments compared 
to the arthritic control. Both Egyptian and European 
high pumpkin oil dose groups have comparable and 
significant plasma TNF-α, ESR, MDA and total anti-
oxidant levels. It is noted that high pumpkin oil doses 
have a much more potent effect rather than lower 
doses on reducing plasma TNF-α. No significant 
change was noticed in ESR and plasma MDA among 
the different oil treatments and doses. Different oil 
treatments normalized Plasma MDA levels except 
for the high dose of the European PSO. The level of 
ESR only normalized upon the administration of the 
Egyptian low dose of PSO. The rats given a high dose 
of Egyptian and European PSO showed no significant 
change in plasma total antioxidants compared to the 
normal control. However, the different oil treatments 
and doses could not normalize the level of TNF-α.
The results of the nutritional parameters of the 
different groups of rats in adjuvant arthritis experi-
ment are shown in Table 4. Final body weight, body 
weight gain, total food intake, and Food efficiency 
ratio decreased significantly in the control arthritic 
rats compared to the normal control. Final body 
Table 2. Inflammation thickness of the injected foot 
(after 13 days of adjuvant arthritis induction) of arthritic 
rats given different doses of PSO compared to the control 
arthritic group
Groups
Inflammation thickness 
(cm) (Mean± SE)
% Inhibition of 
inflammation
Arthritic control 0.400a ± 0.013 -
European high dose 0.217b ± 0.017 46
European low dose 0.200b ± 0.026 50
Egyptian high dose 0.223b ± 0.009 44
Egyptian low dose 0.275b ± 0.017 31
In the same column different letters mean significant differences 
at 0.01probability.
Table 3. Levels of ESR, TNF-α, total antioxidant, and malondialdehyde (MDA) in the different experimental groups
Parameters
ESR
(mm/h)
TNF-α
(pg/ml)
Total antioxidant (nmol/
ml)
MDA
(nmol/ml)
Normal healthy control 1.33c ± 0.21 20.22d ± 0.59 1.88a ± 0.07 2.12c ± 0.21
Arthritic control 4.83a ± 0.31
(263%)
34.52a ± 0.80
(71%)
1.35d ± 0.04
(−28%)
4.92a ± 0.29
(132%)
Egyptian high dose 2.33b ± 0.33
(−52%)
23.72c ± 0.43
(−31%)
1.70abc ± 0.10
(26%)
2.70bc ± 0.22
(−45%)
Egyptian low dose 2.00bc ± 0.26
(−59%)
28.17b ± 0.79
(−18%)
1.55c ± 0.04
(15%)
2.65bc ± 0.23
(−46%)
European high dose 2.50b ± 0.43
(−48%)
24.07c ± 0.58
(−30%)
1.77ab ± 0.08
(31%)
3.07b ± 0.24
(−38%)
European low dose 2.50b ± 0.22
(−48%)
27.47b ± 0.78
(−20%)
1.58bc ± 0.06
(17%)
2.58bc ± 0.10
(−47%)
Results are expressed as mean ± SE of 6 rats.
In each column the same letter means non-significant difference while different letters mean significant differences at 0.05probability.
% change in the row of arthritic control was calculated by comparing arthritic control with normal control. % change in the last 4 rows
was calculated by comparing the arthritic groups given PSO with the arthritic control.
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weight and body weight gain increased significantly 
upon the administration of different PSO types and 
doses compared to the arthritic control. The final 
body weight and body weight gain of these treatments 
matched the normal control except for the high dose 
of the European variety. Compared to the arthritic 
control, the food efficiency ratio increased signifi-
cantly upon administration of different PSO types 
and doses till it matched that of the normal control 
rats. No significant difference in total food intake was 
noticed between the groups given the European PSO 
and the arthritic control. Compared to the arthritic 
control, total food intake increased significantly upon 
administration of either doses of the Egyptian PSO 
variety till matching the normal control.
3.2.3. Cytogenetic parameters in adjuvant arthritic rats
3.2.3.1. Chromosomal aberrations
Rat bone marrow cells were collected from the 
rats of  normal control, adjuvant arthritic control 
and from normal rats given high doses of  either 
European or Egyptian PSO. The results showed no 
significant chromosomal aberrations after treat-
ing normal animals with high doses of  Egyptian 
or European PSO alone compared to the normal 
control. Adjuvant arthritic rats showed an induced 
genotoxicity in rat bone marrow cells represented 
by chromosomal aberrations. It was noticed that 
chromosomal aberrations including and exclud-
ing gaps increased significantly after treatment 
with FCA (p < 0.05) compared to the normal rats 
(Table 5). Different types of  chromosomal aberra-
tions were observed (gaps, breaks, fragments and 
deletion) after treating animals with FCA (Table 5 
and Figure 1).
The Egyptian and European PSO significantly 
reduced the percentages of  chromosomal aberra-
tions produced by FCA in comparison to rats of 
the adjuvant arthritic control group except for the 
Egyptian PSO low dose. The low dose of  Egyptian 
PSO only reduced chromosomal aberrations includ-
ing and excluding gaps without any significance. 
The percentages of  inhibition after treating FCA 
rats with Egyptian PSO reached 20.75% and 49.06% 
Table 4. Nutritional parameters of different experimental groups
Parameters Initial body weight (g) Final body weight (g) Body weight gain (g) Total food intake (g) Food efficiency ratio
Normal healthy 
control
107.3a ± 0.61 167.5a ± 2.39 60.2a ± 2.56 259.0a ± 7.32 0.234ab ± 0.01
Arthritic control 107.7a ± 2.27 142.7c ± 3.04 35.0c ± 3.29 217.2b ± 12.94 0.164c ± 0.01
Egyptian high dose 107.3a ± 2.72 167.8a ± 2.77 60.5a ± 1.43 261a ± 5.17 0.232ab ± 0.008
Egyptian low dose 107.7a ± 1.76 163.2a ± 3.88 55.5a ± 2.80 256.7a ± 7.48 0.216b ± 0.01
European high dose 107.3a ± 2.90 152.3b ± 3.37 45b ± 1.75 216.8b ± 2.16 0.208b ± 0.01
European low dose 107.3a ± 1.74 164.0a ± 3.05 56.7a ± 2.29 223b ± 6.50 0.254a ± 0.005
Results are expressed as mean ± SE of 6 rats.
In each column the same letter means non-significant difference while different letters mean significant differences at 0.05 probability.
Table 5. Number and mean percentages of chromosomal aberrations in rat bone-marrow cells of all experimental groups of the 
adjuvant arthritis experiment
Treatments
Ch. Ab. Including Gaps Ch. Ab. Excluding Gaps Different types of Ch. Ab.
No. % Inhibition % No. % Inhibition % G. Br. Fr. Del.
CN 32 6.4 - 19 3.8 - 13 11 3 5
N Egp HD 34 (ns) 6.8 - 22 (ns) 4.4 - 12 11 8 3
N Eur HD 36 (ns) 7.2 - 21 (ns) 4.2 - 15 10 9 2
Ad.Arth. C 53* 10.6 - 34* 6.8 - 19 14 11 9
Ad.Arth. + Egp LD 42 8.4 20.75 25 5 26.47 17 16 6 3
Ad.Arth. + Egp HD 27++ 5.4 49.06 17+ 3.4 50.00 10 7 8 2
Ad.Arth. + Eur LD 29++ 5.8 45.28 16+ 3.2 52.94 13 9 5 2
Ad.Arth. + Eur HD 25++ 5.0 52.83 14++ 2.8 58.82 11 10 3 1
Total number of scored metaphases 500 (100 metaphases/ animal). Ch. Ab.:Chromosomal aberration; No: Numbers; G.:Gap; Br.: 
Break; Fr.: Fragment; Del.: Deletion. CN: control normal, Egp LD: Egyptian PSO low dose, N Egp HD: Normal rats treated with 
Egyptian PSO high dose, Eur LD: European PSO low dose, N Eur HD: Normal rats treated with European PSO high dose, Ad.Arth. 
C: Rats of control adjuvant arthritic group; Ad.Arth.: Rats with adjuvant arthritis
*: Significant compared to normal control (p < 0.05); ns: Insignificant compared to normal control; ++ & +: Significant in comparison to 
adjuvant arthritis control (+p < 0.05; ++p < 0.01).
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in including gaps and 26.47% and 50% in excluding 
gaps for low and high doses, respectively (Table 5). 
Both low and high doses of  European PSO given 
with FCA injection reduced chromosomal aberra-
tions including and excluding gaps significantly in 
comparison to rats treated with FCA alone. The 
percentages of  inhibition after treating animals 
with FCA and European PSO reached 45.28% and 
52.83% in including gaps and 52.94% and 58.82% 
in excluding gaps for low and high doses, respec-
tively (Table 5).
3.2.3.2. Sperm shape abnormalities
Sperm shape abnormalities are usually taken as 
a characteristic criterion and as an applied test for 
monitoring the mutagenic potential for many dis-
eases or chemicals. In this experimental study, rat 
sperm cells were collected from normal healthy 
rats, normal rats given high doses of  Egyptian or 
European PSO, rats treated with FCA alone or 
in combination with high or low doses of  either 
Egyptian or European PSO to investigate their pro-
tective efficacy. The results showed that the treat-
ment of  normal rats with Egyptian and European 
PSO did not induce sperm shape abnormalities 
in comparison to the non-treated normal control. 
However, control adjuvant arthritic rats showed 
significant sperm shape abnormalities in compari-
son to non-treated rats. The percentage of  sperm 
shape abnormalities (Table 6) was 2.8% (p < 0.001) 
after treatment with FCA in comparison to con-
trol normal rats (0.48%). The main types of  sperm 
shape abnormalities observed were amorphous, 
triangular, banana shape, without hook and small 
head (Figure 2). Both Egyptian and European PSO 
reduced the percentages of  sperm shape abnor-
malities produced by FCA highly significantly 
(p < 0.001) in comparison to adjuvant arthritic con-
trol rats. The percentages of  inhibition gradually 
increased with increasing doses of  PSO. The per-
centages of  inhibition reached 32.14% and 35.36% 
with low and high doses of  Egyptian PSO, respec-
tively. The inhibition percentage was 37.5% and 
Figure 1. Metaphases with different chromosome 
aberrations in rat bone marrow cells after treatments with 
arthritic adjuvant for 13 days, (a) normal metaphase, 
(b) chromatid break, (c) fragment, (d) deletion. (X1250).
Table 6. Number and mean percentages of sperm shape abnormalities in rat sperms of the experimental groups of adjuvant 
arthritis experiment.
Treatments
No. of 
scored 
sperms
Abnormal sperms Different types of sperm shape abnormalities
No. Mean (%) ± SD Inhibition % Amorphous Triangular Banana shape
Without 
hook
Small 
Head
CN 5024 24 0.48 ± 0.13 - 10 1 4 7 2
N EgpHD 5029 29 0.58 ± 0.21 (ns) - 10 0 0 16 3
N Eur HD 5028 28 0.56 ± 0.19 (ns) - 11 1 2 13 1
Ad.Arth.C 5144 144 2.80 ± 0.14a - 58 15 15 48 8
Ad.Arth. + Egp LD 5097 97 1.90 ± 0.35b 32.14 33 9 19 34 2
Ad.Arth. + Egp HD 5092 92 1.81 ± 0.29b 35.36 25 13 22 32 0
Ad.Arth. + EurLD 5089 89 1.75 ± 0.25b 37.50 24 11 24 28 2
Ad.Arth. + EurHD 5084 84 1.65 ± 0.13b 41.07 18 5 28 31 2
No: Numbers, CN: control normal, Egp LD: Egyptian PSO low dose, N Egp HD: Normal rats treated with Egyptian PSO high dose, 
Eur LD: European PSO low dose, N Eur HD: Normal rats treated with European PSO high dose, Ad.Arth. C: Rats of control adjuvant 
arthritic group, Ad.Arth.: Rats with adjuvant arthritis.
At least 1000 sperms/animal were scored (6 rats/group).
a Significance in comparison to non-treated rats (control normal) (p < 0.001), (ns): Insignificant compared to normal control; 
b Significance in comparison to adjuvant arthritis control (p < 0.001).
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41.07% after treatment with low and high doses of 
European PSO, respectively (Table 6). These results 
indicated that European oil is slightly more effective 
than Egyptian oil.
3.2.3.3. DNA fragmentation assay
The liver cells were collected from all experi-
mental animals and the percentages of  DNA 
fragmentation were recorded. Both Egyptian and 
European oil did not induce DNA damage in the 
liver cells of  normal healthy rats in comparison 
to non-treated animals (normal control). The per-
centages of  DNA fragmentation were highly sig-
nificant (5.86%; p < 0.001) in animals treated with 
FCA (adjuvant arthritic control) in comparison to 
the normal healthy control (3.4%) (Table 7). Both 
Egyptian and European pumpkin oils reduced the 
DNA fragmentation induced by FCA. The reduc-
tion percentages were highly significant (p < 0.001) 
in comparison to animals treated with FCA alone. 
The percentages of  inhibition were 30.92% and 
37.52% after treatment with low and high doses 
of  Egyptian oil, respectively. The inhibition per-
centages of  DNA fragmentation were 36.04% and 
44.21% upon treatment with low and high doses of 
European oil, respectively (Table 7) which indicated 
a dose-dependent effect.
4. DISCUSSION
In the present research, the anti-inflammatory 
activity of  two varieties of  PSO, an Egyptian and 
a European, was studied in a chronic inflammatory 
model of  adjuvant arthritis in rats. These types of 
oils were selected as they are expected to be rich 
in bioactive ingredients which could have antioxi-
dant, free radical scavenging capacity and anti-
inflammatory effects.
In the present study, the induction of AA in rats 
produced high oxidative stress reflected in elevated 
plasma MDA and reduced total antioxidant capac-
ity. Also inflammatory biomarkers represented by 
ESR and plasma TNF-α were significantly elevated 
in AA rats with the induction of foot paw inflam-
mation. In support of the present work, arthritis is 
described as being a condition that involves systemic 
oxidative stress (Strosova et al., 1995). In previous 
studies, it was shown that plasma oxidative stress 
and inflammatory biomarkers increased in both AA 
Figure 2. (a)- Normal sperm with a definite head and a marked hook from a control rat. (b–f) Different types of sperm shape 
abnormalities in rats treated with Freund’s complete Adjuvant; (b) amorphous head; (c) triangular head; (d) without hook; 
(e) banana shape; (f) small head. (X1250).
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rats and in patients with RA (Al-Okbi et al., 2000a; 
2000b; 2011; Stepaniak et al., 1995).
TNF-α is a potent pro-inflammatory cytokine 
that plays an important role in inflammation. It 
binds to its cellular receptor TNF receptor 1, which 
triggers signaling cascades that activate NF-κB 
and activator protein 1 transcription factors. Pro-
inflammatory cytokines like IL-1β and TNF-α 
could thus help to propagate the extension of a 
local or systemic inflammatory process by activat-
ing NF-κB, forming a positive feedback mechanism 
which exaggerates the inflammatory process (Sonis, 
2002).
Overproduction of lipid peroxide oxidative stress 
marker, MDA, was noticed in AA rats (Zhang et al., 
2014). AA was monitored by hind paw volume and 
high level of MDA. During inflammatory joint dis-
eases, like adjuvant-induced arthritis, phagocytes 
accumulate in the joints and produce superoxide 
and hydroxyl radicals as well as hydrogen peroxide. 
Such reactive oxygen species might contribute to the 
elevated ESR, plasma MDA, and TNF-α observed 
in the arthritic model of inflammation. An elevation 
of the oxidative damage marker such as blood MDA 
with reduction in total antioxidants in the present 
study demonstrated a disturbance in the oxidant to 
antioxidant balance in favor of lipid peroxidation, 
which could lead to the tissue damage seen in the 
disease. These results suggest the importance of 
therapeutic co-administration of antioxidants with 
conventional drugs in such condition.
Paw swelling, body weight loss and overproduc-
tion of serum TNF-α and MDA were reported as 
the main pathological signs in FCA-induced arthri-
tis in rats (Zhang et al., 2014). Paw volume and ESR 
were evaluated as arthritic markers (Banji et  al., 
2014). During arthritis, TNF-α has been implicated 
in the pathological mechanisms of synovial tis-
sue proliferation, joint destruction and apoptosis. 
Hemshekhar et al. (2013) demonstrated a signifi-
cant reduction in arthritis-induced paw swelling and 
body weight regain, establishing a close relationship 
between inflammation and loss of body weight. 
TNF-α played a role in the increased prevalence of 
low body mass which has been reported in arthritic 
individuals (Kaufmann et al., 2003). The decrease in 
body weight gain and food efficiency ratio in the con-
trol AA rats in the present study is similar to that in 
rheumatoid arthritis patients where the loss of lean 
tissues could be due to tissue destruction. Elevated 
TNF-α in arthritis could contribute in cartilage and 
bone degeneration through the activation of extra-
cellular matrix degrading enzymes. The increase in 
TNF-α in the present study could thus explain the 
loss in weight gain. The enhanced degradation of 
muscle protein and muscle wasting in experimental 
arthritis might have a hand in body weight reduc-
tion. The decrease in total food intake in adjuvant 
arthritis rats in the current study is similar to the 
observed anorexia in RA patients and could partici-
pate in reducing body weight gain.
The administration of both PSOs to arthritic rats 
in the present study produced significant improve-
ments in inflammatory and oxidative stress bio-
markers together with a reduction in inflammation 
thickness. These effects are certainly attributed to 
the presence of antioxidant and anti-inflammatory 
constituents such as tocopherols, carotenoids, phy-
tosterols, and phenolic compounds in the POs. The 
variation in degree of improvements may be related 
to the different contents and concentration of bio-
active constituents and their synergistic effects. 
The present study showed the presence of phenolic 
compounds and beta- carotene in both varieties of 
PSOs. Also, the two varieties of PSOs were reported 
previously to contain phytosterols, unsaturated fatty 
acids, and tocopherols (Al-Okbi et al., 2014). These 
ingredients could collectively render the oils their 
antioxidant and anti-inflammatory activity.
Egyptian and European PSOs significantly inhib-
ited the elevated plasma levels of TNF-α and MDA, 
thereby reducing the severity of inflammation as 
noticed from the reduced paw inflammation thick-
ness. Eventually, elevated ROS promotes liver dam-
age by elevating the levels of lipid peroxides. Lipid 
peroxides, represented in the present study by MDA, 
could behave as a secondary toxic trigger causing 
further damage by modulating membrane fluid-
ity, permeability and transport in arthritic patients. 
Thus the level of MDA may be a sensitive marker 
Table 7. Mean percentage of DNA fragmentation 
induced in rat liver cells injected with FCA with or without 
daily oral doses of Egyptian or European pumpkin oil 
(40 and 500 mg/kg b. wt.)
Treatments
DNA 
fragmentation
Mean (%) ± SD Inhibition %
CN 3.40 ± 0.26 -
N Egp HD 3.15 ± 0.51 -
N Eur HD 3.90 ± 0.69 -
Ad.Arth.C 5.86 ± 0.74a -
Ad.Arth. + Egp LD 4.04 ± 0.90b 30.92
Ad.Arth. + Egp HD 3.66 ± 0.18b 37.52
Ad.Arth. + Eur LD 3.74 ± 0.78b 36.04
Ad.Arth. + Eur HD 3.27 ± 0.28b 44.21
CN: normal control, Egp LD: Egyptian PSO low dose, N Egp 
HD: Normal rats treated with Egyptian PSO high dose, Eur LD: 
European PSO low dose, N Eur HD: Normal rats treated with 
European PSO high dose, Ad.Arth. C: Rats of control adjuvant 
arthritic group, Ad.Arth.: Rats with adjuvant arthritis (6 animals /
group were investigated).
a Significance in comparison to normal control (p < 0.001); 
b Significance in comparison to adjuvant arthritis control 
(p < 0.001).
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of oxidative damage during arthritis and treatment 
with PSO which reflects the potent antioxidant and 
free radical scavenging activity of PSO.
PSOs have a significant inhibitory effect on foot 
inflammation and this ability to reduce edema may 
be related to its inhibitory action on TNF-α and 
ESR which reflect their anti-inflammatory activity. 
Also both Egyptian and European PSO doses sig-
nificantly elevate the antioxidant capacity and thus 
they may play an important role in reducing the oxi-
dative stress associated with the arthritic condition, 
and therefore has the potential to be used as an anti-
arthritic agent.
It was noticed that all treatments produced a sig-
nificant increase in body weight gain and food effi-
ciency ratio which is reflected in the improvement of 
AA condition.
The presence of α, δ and γ-tocopherol in PSO 
(Al-Okbi et al., 2014) could have a significant impact 
on improving the changes in AA rats. The phenolic 
content and the considerable concentration from 
both tocopherol and β-carotene in PSO may explain 
the antioxidant and anti-inflammatory effects. The 
presence of a high phenolic content was reported 
to play an anti-arthritic role through lowering ESR 
and restoring body weight (Gupta et al., 2014).
Antioxidants play an important role in reliev-
ing arthritis in rats (Zhang et al., 2014). Chronic 
administration of PSO in the present study caused a 
remarkable elevation of serum antioxidant levels 
and a marked inhibition of paw edema that could 
be  attributed to its high content of the aforemen-
tioned antioxidants.
PSO administration improved biochemical 
parameters studied in the present research during 
chronic arthritis which could be ascribed to the 
high level of unsaturated fatty acids in PSO and 
other antioxidants. Previously, extra-virgin olive 
oil was reported to reduce inflammation and carti-
lage-matrix degradation in a mice model of arthri-
tis which was assigned to the adequate fatty acid 
profile and the presence of high phenolic content 
in the oil (Rosillo et al., 2016). Similarly, evening 
primrose oil could reduce the pro-inflammatory 
mediators in a model of fibromyalgia syndrome in 
mice (Montserrat-de la Paz et al., 2013) and in RA 
patients (Al-Okbi et al., 2000a) which might most 
probably be due to the presence of polyunsaturated 
fatty acids particularly gamma- linolenic acid. In 
another study, functional foods containing either 
fish oil or primrose oil showed beneficial effects in 
a rat model of arthritis due to their high levels of 
polyunsaturated fatty acids (Al-Okbi et al., 2012).
The present study indicated that AA has a highly 
significant genotoxic effect on rat bone marrow cells 
as well as sperm and liver DNA. Our results are in 
agreement with a previous study which reported the 
induction of structural and numerical aberrations 
in the synovial fibroblasts in RA patients and other 
inflammatory joint diseases (Wyllie et al., 1980). 
The current work also indicated DNA fragmenta-
tion induced by AA in rat liver cells similar to the 
work of Wyllie et al. (1980).
Oxidative metabolism is considerably enhanced in 
the liver of AA rats. The livers of adjuvant-induced 
arthritis rats show a pronounced high oxidative 
stress which is the consequence of both a stimulated 
pro-oxidant system and reduction in antioxidant 
defense represented by the lowering in catalase and 
glutathione peroxidase activities (Kelmer-Bracht 
et al., 2003). This liver high oxidative stress could 
be the cause of the observed DNA damage in the 
AA rats in the present study. The mRNA levels of 
mdr1a and mdr1b encoding P-glycoprotein (P-gp) 
decreased significantly in the livers of the AA rats 
(Kawase et al., 2014). In arthritic rats, it was observed 
previously that there was a significant elevation 
in DNA damage and genotoxicity (Al-Okbi et al., 
2011). Mutation rates might be increased due to the 
elevated level of DNA damage in adjuvant arthri-
tis. The present study showed the protective role of 
the tested PSOs by inhibiting the genotoxic effects 
induced by adjuvant arthritis and the protection of 
cells against oxidative DNA damage. The bioactiv-
ity of PO could be attributed to the presence of the 
aforementioned bioactive constituents that could 
impart antioxidant and anti-inflammatory activity.
It was reported that carotenoids reduced the induc-
tion of micronuclei in polychromatic erythrocytes in 
mice bone-marrow cells (Rauscher et al., 1998). The 
protective effect of nut oil was demonstrated against 
free radical capacity due to the presence of tocopher-
ols. Tocopherol itself was shown previously to possess 
protective effects against the induced genotoxicity 
in mice bone-marrow cells (Arranz et al., 2008). So 
tocopherols in combination with the different func-
tional ingredients of PSO in the present study could 
have synergistic anti-genotoxicity. In the current 
research, the mutagenic effect and DNA fragmenta-
tion in AA was minimized by the oral administration 
of POs which significantly inhibited the sperm shape 
abnormalities, DNA fragmentation and chromo-
somal aberrations of somatic and germ cells. Total 
phenolics have been reported to have anti-mutagenic 
effects (Batista et al., 2016), so the phenolic content 
of PSO could have a similar effect.
The essential fatty acid, linoleic acid accounts for 
nearly one-third of the total fatty acid in pumpkin 
seeds while the contribution of α-linolenic acid was 
considerably low (Glew et al., 2006; Tsaknis et al., 
1997). These fatty acids could participate in the bio-
activity of PSO.
Mini Paulista and Nova Caravela pumpkin vari-
eties showed high amounts of total phenolic com-
pounds in the lipid fractions and in the seeds. It was 
also found that γ-tocopherol is the isomer that stood 
out in the lipid fractions and in the seeds, mainly in 
Menina Brasileira (Veronezi and Jorge, 2012).
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5. CONCLUSIONS
The present study showed that both the Egyptian 
and European varieties of PSO improved the bio-
chemical and nutritional changes in an adjuvant 
arthritis model and reduced the genotoxicity and 
paw inflammation which nominate PSO as being a 
protective agent towards RA or complementary to 
therapy used for this disease. The bioactivity of PSO 
might be ascribed to its contents of total phenolics 
and beta-carotene determined in the present study, 
in addition to phytosterols, unsaturated fatty acids 
and tocopherols, as reported previously.
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